Prosecution Insights
Last updated: July 17, 2026

Birchwood Ip- Chk001

9 pending office actions • 9 clients • 9 examiners • 9 art units • 0 of 9 (0%) have an AI response strategy ready • 66 patents granted in the last 365 days

Quality Metrics (n=477 apps, methodology: how we score firms)

94.4%
Allowance Rate
n=477
+0.31σ
Allowance Rate (norm)
n=477
1.0
OAs to Allowance
n=386
-1.68σ
OAs to Allow (norm)
n=386
764 days
Time to Allowance
n=386
+5.8pp
Interview Lift
n=477
3.2%
RCE Rate
n=477
0.0%
Appeal Rate
n=477

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=3 (min 20)
78.3%
§102 Overcome
n=23
60.9%
§103 Overcome
n=69
94.7%
§112 Overcome
n=94

Specialization & Scale

E03C, F16K, F21V
Top CPC Subclasses
11%
Top-3 CPC Share
n=477
0
Practitioners
n=477
Apps / Practitioner
n=477 (min 20)

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
8
Medium (89%)
0
Easy (0%)
1
Unknown (11%)

Rejection Statute Mix

BucketCases
§103 only7 (78%)
§102 only1 (11%)
No statute on record1 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
22% of docket
1
Mechanical / Eng
11% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BETIT, JACOB F 1 36.1% +16.6%
LU, JIONG-PING 1 83.6% +7.8%
GILLETT, JENNIFER ANN 1 28.6% +37.6%
MURESAN, ANA Z 1 75.1% +31.3%
STEFANON, JUSTIN 1 51.1% +48.0%
JADHAO, SAMADHAN JAISING 1 52.0% +45.8%
DOLE, TIMOTHY J 1 74.4% +6.9%
EDWARDS, JESSICA FAYE 1 43.2% +47.9%
PETRASH, HILARY ANN 1 63.3% +53.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18294174 CHEMICAL-MECHANICAL COMBINED MACHINING METHOD FOR SILICON CARBIDE SURFACE LU, JIONG-PING 26d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18288197 SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR GILLETT, JENNIFER ANN

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18434764 BEVERAGE CONTAINER AND COVER UNIT BETIT, JACOB F 324d overdue
18003018 METHOD FOR PREPARING RECOMBINANT HUMAN EXTRACELLULAR MATRIX STRUCTURAL PROTEIN EDWARDS, JESSICA FAYE 19d
17681855 Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof PETRASH, HILARY ANN 19d
18275226 S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor JADHAO, SAMADHAN JAISING 47d
18288197 SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR GILLETT, JENNIFER ANN
17610458 KETTLE-TYPE CONTINUOUS PRODUCTION METHOD FOR GLYCINE MURESAN, ANA Z
18228682 Noise reduction and shock absorption structure for tubular motor STEFANON, JUSTIN

Client Portfolio (9 clients)

Top Art Units

Art UnitApps
37351
17131
17891
16921
28341
16721
28471
16571
16441

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18434764 BEVERAGE CONTAINER AND COVER UNIT Zhejiang Hasa Science&Technology Co., Ltd. BETIT, JACOB F 3735 §102 Non-Final OA 324d overdue Pending Feb 06, 2024
18294174 CHEMICAL-MECHANICAL COMBINED MACHINING METHOD FOR SILICON CARBIDE SURFACE Huaqiao University LU, JIONG-PING 1713 §103 Non-Final OA 26d Pending Feb 01, 2024
18288197 SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR Xiamen Yanjan New Material Co., Ltd. GILLETT, JENNIFER ANN 1789 §103 Final Rejection Pending Oct 25, 2023
17610458 KETTLE-TYPE CONTINUOUS PRODUCTION METHOD FOR GLYCINE Huayang New Material Technology Group Co., Lt MURESAN, ANA Z 1692 §103 Non-Final OA Pending Sep 12, 2023
18228682 Noise reduction and shock absorption structure for tubular motor Harda Intelligent Technologies Co., Ltd. STEFANON, JUSTIN 2834 §103 Non-Final OA Pending Aug 01, 2023
18275226 S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor National Vaccine And Serum Institute (Nvsl) JADHAO, SAMADHAN JAISING 1672 §103 Non-Final OA 47d Pending Aug 01, 2023
18036426 Thin-Film Capacitor Core Xiamen Faratroinic Co., Ltd. DOLE, TIMOTHY J 2847 §103 Final Rejection 56d overdue Pending May 11, 2023
18003018 METHOD FOR PREPARING RECOMBINANT HUMAN EXTRACELLULAR MATRIX STRUCTURAL PROTEIN Guangzhou Jida Biological Technology Co., Ltd. EDWARDS, JESSICA FAYE 1657 §103 Non-Final OA 19d Pending Dec 22, 2022
17681855 Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof Institute Of Hematology And Blood Diseases Hospital, Chinese Academy Of Medical Sciences PETRASH, HILARY ANN 1644 Other Final Rejection 19d Pending Feb 28, 2022

Managing Birchwood Ip- Chk001's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month